Evidence map›Paper›PMID 30809143›Full record

ArticleFrontiers in aging neuroscience2019

Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer's Disease.

Sara A Galle, Ashley van der Spek, Madeleine L Drent, Michael P Brugts, Erik J A Scherder, Joseph A M J L Janssen, M Arfan Ikram, Cornelia M van Duijn

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Extracellular vesicles, the emerging mirrors of brain physiopathology.International journal of biological sciences · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  13. Review
  14. Circulating IGFBP-2: a novel biomarker for incident dementia.Annals of clinical and translational neurology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sara A GalleDepartment of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Ashley van der SpekDepartment of Genetic Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands.
Madeleine L DrentDepartment of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Michael P BrugtsDepartment of Internal Medicine, Ikazia Ziekenhuis, Rotterdam, Netherlands.
Erik J A ScherderDepartment of Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Joseph A M J L JanssenDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
M Arfan IkramDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands.
Cornelia M van DuijnDepartment of Genetic Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands.
Erasmus MC · NLVrije Universiteit Amsterdam · NLIkazia Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseaseapolipoprotein Edementiagenetic epidemiologyinsulin-like growth factor IKIRA assay

Identifiers

PMID30809143
PMCPMC6380107
OpenAlexW2913638709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.